Abstract 1299: Cost-effectiveness analysis of circulating tumor DNA-based molecular profiling platforms for the detection of <i>EGFR</i> mutations in lung cancer

Authors: Pim Rozendal, Paul van der Leest, Elise M. van der Logt, Naomi Rifaela, Inge Platteel, Frank J. Scherpen, Harry J. Groen, Léon C. van Kempen, Ed M. Schuuring

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-1299

Source: Full article